Summary of PERRIGO CO - Yahoo! Finance

Results of Operations and Financial Condition, Financial Statements and Exhibits

ITEM 2.02. Results of Operations and Financial Condition

On February 3, 2009, Perrigo Company (Company) released earnings for the second quarter and fiscal year 2009.

The earnings release contains non-GAAP measures which are defined as a financial measure of the Company's performance that excludes or includes amounts thereby differentiating it from the most directly comparable measure presented in the financial statements that are calculated and presented in accordance with U.S. Generally Accepted Accounting Principles (GAAP). Pursuant to the requirements of Regulation G, the Company has provided a reconciliation for gross profit, operating expenses, operating income, net income and earnings per share within its earnings release to the most directly comparable U.S. GAAP measure for these non-GAAP measures.

The Company excludes the items listed below in the applicable period when monitoring and evaluating the on-going financial results and trends of its business due to the unusual nature of these items. The Company believes that presenting operating results and guidance excluding these items is also useful for investors since it provides important insight into the Company's on-going core business operations on a normalized basis.

Items excluded from reported results and guidance:

Fiscal 2009 Results and Guidance
- A loss on asset exchange

- Charges associated with the step-ups in value of inventory acquired

- Impairment of fixed assets

- A write-off of in-process research and development

- An other-than-temporary impairment loss on investments

The press release related to Perrigo's earnings is attached as Exhibit 99.1.

The information in this Report is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Report shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.